Kodiak Sciences Inc. (KOD)
BMV
Real-time Data
02:30 PM
Day's Range
749.0052 wk Range
51.00Overview - KOD - Kodiak Sciences Inc.
Key Statistics
Valuation
Enterprise Value
829.95B
P/E (Trailing)
‪-173.37‬
PEG Ratio
‪-89.29‬
Price / Book
‪32.17‬
EV / EBITDA
‪-203.07‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-60.44%‬
Return on Equity
‪-368.37%‬
Ownership
Shares Outstanding
62.83M
Float
39.55M
Held by Insiders
‪5.16%‬
Held by Institutions
‪102.42%‬
Price stats
Beta
‪2.18‬
50-Day Avg
‪749.00‬
200-Day Avg
‪599.74‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - KOD - Kodiak Sciences Inc.
Peers - KOD - Kodiak Sciences Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
Profile Summary - KOD - Kodiak Sciences Inc.
About
Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for retinal diseases. The company works on treatments for conditions that affect the retina and can lead to vision loss, with a portfolio centered on ophthalmology and retinal vascular disorders. Its current programs…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
